Moreover, our research uncover that the upregulation of SMAD4 promotes the expression of the NK cell activating receptor NKG2D, thereby promoting the activation of the NKG2DL-NKG2D regulatory axis and enhancing the cytotoxic effect of NK cells to CRC cells. The gene discussed is KLRK1; the disease is colorectal carcinoma.